Highly Potent Drugs

Jun 03, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Effective containment in API and drug-product manufacturing encompasses a variety of process, equipment, and operational issues.
Jun 02, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Effective containment in API and drug-product manufacturing encompasses a variety of process, equipment, and operational issues.
Apr 01, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
The main challenge for tablet manufacturers processing highly potent APIs (HPAPIs) is to protect equipment operators from the inhalation of airborne particles and prevent skin contact with the product during the entire production process: dispensing, granulation, tablet compression, coating and packaging.
Jan 14, 2011
By Pharmaceutical Technology Editors
Dishman is giving a step further in its strategy to manufacture high potency (HiPo) Active Pharmaceutical Ingredients (APIs).
Oct 02, 2010
Pharmaceutical Technology
By Pharmaceutical Technology Editors
A recently released industry guide outlines a science- and risk-based approach to control the risk of cross-contamination.
Sep 15, 2010
Equipment and Processing Report
By Pharmaceutical Technology Editors
US Pharmacopeia apparatuses for testing the dissolution of transdermal drugs produce good, reproducible results. Yet some scientists believe that further modifications could improve the instruments? suitability for this application.
Sep 01, 2010
Pharmaceutical Technology Europe
The main advantage of outsourcing highly potent API (HPAPI) manufacture is that it eliminates the need to invest in expensive containment infrastructure, which can also be complex to engineer, install and maintain.
Aug 18, 2010
Equipment and Processing Report
By Pharmaceutical Technology Editors
Making highly potent active pharmaceutical ingredients (HPAPIs) can be costly because the process often requires equipment specialized to achieve containment and extra attention to safety concerns. Pharmaceutical professionals may wonder whether disposable components, which have reduced the cost of some operations, might be appropriate in the manufacture of HPAPIs.
Sep 01, 2009
Pharmaceutical Technology
The author describes the approach taken to develop a facility dedicated to handling potent and cytotoxic drug substances.
Jul 02, 2009
Pharmaceutical Technology
By Pharmaceutical Technology Editors
High-potency manufacturing of active pharmaceutical ingredients is a growing and specialized capability.
native1_300x100
lorem ipsum